Robert Kruger, Senior Executive Editor, Cancer Discovery and Editorial Director of Publications at AACR, shared on LinkedIn:
“As an editor, one of the most rewarding aspects of my role is helping to highlight emerging areas of cancer research that have the potential to make a meaningful difference for patients. That’s one reason I’m especially looking forward to attending the AACR Special Conference in Cancer Research: Breaking Barriers in the Fight Against Rare Cancers in Vancouver.
The conference will showcase exciting advances across rare cancer biology, diagnostics, immunotherapy, clinical trial design, and translational research, areas where innovation is urgently needed and where discoveries can have impact far beyond individual tumor types.
The meeting also provides a timely opportunity to highlight recent studies in the AACR journals related to the topic, “Rare Cancers at the Frontier of Precision Oncology.” This collection I curated showcases studies that are advancing our understanding of rare cancers through cutting-edge approaches in genomics, immune profiling, drug discovery, and clinical investigation. These efforts are revealing new biological vulnerabilities and opening new avenues for treatment.
I am particularly looking forward to hearing from and meeting several speakers whose work is featured in the collection, including Andy Futreal, Pavlos Msaouel, MD, PhD, Sanford R Simon, Sandra D’Angelo, and Paul Huang.
Rare cancers may be individually uncommon, but together they affect millions of patients worldwide. Continued collaboration across disciplines will be essential to ensure that every patient with a rare cancer has effective treatment options and that, one day, all cancers are rare.
For anyone attending, please let me know if you want to connect.”
AACR Special Conference in Cancer Research: Breaking Barriers in the Fight Against Rare Cancers
Rare Cancers at the Frontier of Precision Oncology.
Other articles about Rare Cancers on OncoDaily.